top of page

No-Exam Term Life Insurance with GERD: How Reflux Is Typically Underwritten

Written by: Jeff Schmidt | Licensed Insurance Broker | CarePro Insurance Content reviewed for accuracy. Not legal, tax, or financial advice.

GERD is common. Underwriting usually looks at whether symptoms are controlled with medication and whether there's been any complication or abnormal testing.

  • Instant online pricing

  • No phone calls required

  • No pressure from agents

Controlled vs Complicated GERD

Symptom frequency and whether medication controls it

Any testing (endoscopy) and documented findings

Red flags: persistent symptoms, swallowing issues, weight loss

GERD - gastroesophageal reflux disease - is among the most frequently reported GI conditions in life insurance underwriting, and in the majority of cases it is not a significant obstacle to coverage. The dividing line underwriters draw is between GERD that is well controlled on a stable medication regimen and GERD that has caused structural damage to the esophagus or that remains symptomatic despite treatment. Those two situations are underwritten quite differently, and understanding which category your case falls into helps you anticipate what the review process will look like. Applicants who can clearly describe a stable medication history and absence of ongoing complications tend to move through accelerated underwriting programs without significant friction or documentation requests.

Long-term proton pump inhibitor (PPI) use on its own is not a red flag in underwriting. What draws more attention is frequent dose escalation - meaning the prescribing physician has had to repeatedly increase the strength or frequency of the medication to keep symptoms at bay - or persistent breakthrough symptoms despite therapy. Those patterns suggest the reflux is not fully controlled and raise questions about whether an endoscopic evaluation is warranted or already pending. Carriers are less concerned about how many total years you have been on a PPI than they are about whether the current dose is actually working and whether the prescribing pattern reflects a stable situation or an ongoing effort to achieve adequate symptom control.

Endoscopy findings are a meaningful fork in the road for GERD underwriting because they establish whether the reflux has caused structural changes. Uncomplicated GERD that has never required endoscopy, or that produced a normal result, looks very different from erosive esophagitis, peptic ulceration, or Barrett's esophagus found on upper endoscopy. Barrett's esophagus - a condition where the normal esophageal lining is replaced by intestinal-type cells due to chronic acid exposure - is graded by the degree of cellular change present. Non-dysplastic Barrett's with a documented surveillance endoscopy schedule is generally treated differently than low-grade or high-grade dysplasia, with the latter two categories typically resulting in postponement or decline at most carriers until the dysplasia has been treated and confirmed stable on follow-up biopsy.

H. pylori (Helicobacter pylori) is a bacterial co-factor that can complicate GERD underwriting when it appears in the history. H. pylori infection is associated with peptic ulcer disease and can worsen reflux symptoms, and underwriters may ask whether it was tested for and, if found, whether eradication therapy was completed and confirmed with follow-up testing such as a urea breath test or stool antigen test. Active H. pylori adds a GI ulcer risk dimension to the picture that extends beyond reflux alone, while a confirmed eradication with a documented negative follow-up result closes that question cleanly and removes it as an ongoing concern in the application.

Applicants with straightforward, well-controlled GERD on a stable regimen typically find the underwriting process moves efficiently once the relevant details are organized. The most useful preparation is knowing your medication name and current dose, the date of any endoscopy you have had and the summary of what it showed, and whether your symptoms are currently controlled at your present regimen without escalation. If you have never had an endoscopy and your symptoms are mild and stable, that is worth noting accurately - carriers do not automatically require one for every GERD case, and the absence of documented complications is itself a meaningful clinical data point. Keeping those details consistent across all carrier applications ensures that quote comparisons reflect the same clinical picture rather than generating different offers because different assumptions were made about symptom severity, medication history, or testing results.

For the full no-exam term life overview (including how accelerated underwriting works), see: https://www.careproinsurance.com/instant-term-life-insurance

Educational content only. Nothing here should be taken as legal, medical, or tax advice; it's informational content. Don't treat quoted numbers as locked in; underwriting has the final say on pricing.

Frequently Asked Questions

Can I get no-exam term life insurance with GERD?

Often, yes. Many people with controlled GERD qualify, especially when symptoms are stable and there are no complications. Carrier rules vary.

What GERD details do carriers usually ask about?

Common questions include symptom frequency, medications, whether symptoms are controlled, and whether you've had testing like an endoscopy and the results.

Does Barrett's esophagus affect life insurance underwriting?

It can. Barrett's may lead to additional underwriting review and documentation. The impact depends on severity, follow-up plan, and the overall health profile.

Will I need a medical exam because of GERD?

Not always. Some cases qualify for accelerated/no-exam paths, but carriers may request follow-up information depending on symptoms and testing history.

How can I avoid quote surprises with GERD?

Be consistent and specific about symptoms, medications, and testing history. Quotes can change if underwriting findings differ from what the quote assumed.

What is Barrett's esophagus and how does it affect underwriting?

Barrett's esophagus is a change in the esophageal lining caused by chronic acid exposure. Non-dysplastic Barrett's with regular surveillance is treated differently than cases with low-grade or high-grade dysplasia - dysplastic cases typically result in postponement or decline until the condition is treated and confirmed stable.

Does H. pylori history matter in GERD-related underwriting?

It can. Active H. pylori adds a peptic ulcer risk dimension to the application. Underwriters may ask whether eradication therapy was completed and confirmed with follow-up testing. A documented negative post-treatment test generally closes that question.

If I have never had an endoscopy, does that automatically flag my GERD application?

Not automatically. Carriers do not require an endoscopy for every GERD case. If symptoms are mild and stable and no complications have been documented, many applicants move through review without one. The question is usually about current symptom control, not procedure history alone.

bottom of page